HK1054945A1 - Macrolides - Google Patents

Macrolides

Info

Publication number
HK1054945A1
HK1054945A1 HK03107352A HK03107352A HK1054945A1 HK 1054945 A1 HK1054945 A1 HK 1054945A1 HK 03107352 A HK03107352 A HK 03107352A HK 03107352 A HK03107352 A HK 03107352A HK 1054945 A1 HK1054945 A1 HK 1054945A1
Authority
HK
Hong Kong
Prior art keywords
macrolides
macrolactam
pimecrolimus
epimerization
concomitant
Prior art date
Application number
HK03107352A
Other languages
English (en)
Inventor
Gerhard Fleissner
Helmut Hacker
Ernst Kusters
Gerhard Penn
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1054945A1 publication Critical patent/HK1054945A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
HK03107352A 2000-05-22 2003-10-14 Macrolides HK1054945A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0012383.6A GB0012383D0 (en) 2000-05-22 2000-05-22 Organic compounds
PCT/EP2001/005836 WO2001090110A1 (en) 2000-05-22 2001-05-21 Macrolides

Publications (1)

Publication Number Publication Date
HK1054945A1 true HK1054945A1 (en) 2003-12-19

Family

ID=9892108

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03107352A HK1054945A1 (en) 2000-05-22 2003-10-14 Macrolides

Country Status (15)

Country Link
US (1) US6706727B1 (xx)
EP (1) EP1289997B1 (xx)
JP (2) JP4043239B2 (xx)
CN (1) CN1229381C (xx)
AT (1) ATE257481T1 (xx)
AU (1) AU2001278428A1 (xx)
CA (1) CA2405593C (xx)
DE (1) DE60101739T2 (xx)
DK (1) DK1289997T3 (xx)
ES (1) ES2214436T3 (xx)
GB (1) GB0012383D0 (xx)
HK (1) HK1054945A1 (xx)
PT (1) PT1289997E (xx)
TR (1) TR200400723T4 (xx)
WO (1) WO2001090110A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618952D0 (en) * 1996-09-11 1996-10-23 Sandoz Ltd Process
CA2442969A1 (en) * 2001-05-09 2002-11-14 Novartis Ag Methods for selective immunomodulation using pimecrolimus
GB0200429D0 (en) * 2002-01-09 2002-02-27 Novartis Ag Organic compounds
EP1539041A1 (en) * 2002-07-25 2005-06-15 Avantec Vascular Corporation Devices delivering therapeutic agents and methods regarding the same
EP1740168A2 (en) * 2004-04-21 2007-01-10 Advanced Ocular Systems Limited Antiprostaglandins for the treatment of ocular pathologies
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
GT200500282A (es) * 2004-10-12 2006-05-04 Heteroatomos conteniendo compuestos triciclicos.
WO2006060614A1 (en) * 2004-12-01 2006-06-08 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Methods for preparing pimecrolimus
CN104250255B (zh) * 2013-06-28 2016-05-25 北京大学 一种柔性内酰胺类大环分子及其制备方法
US10975097B2 (en) 2017-05-01 2021-04-13 Meda Ab Process to convert technical ascomycin into purified pimecrolimus
EP3741367A1 (en) 2019-05-21 2020-11-25 Premark Pharma GmbH Treatment of ocular disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430455D0 (en) * 1984-12-03 1985-01-09 Fujisawa Pharmaceutical Co Fr-900506 substance
NZ235991A (en) * 1989-11-09 1993-05-26 Sandoz Ltd Macrolide compounds and pharmaceutical compositions thereof
JP3362394B2 (ja) * 1995-09-19 2003-01-07 藤沢薬品工業株式会社 エアゾール組成物
DK1056454T3 (da) * 1998-02-23 2003-08-18 Fujisawa Pharmaceutical Co Anvendelse af makrolidforbindelser til behandling af glaukom

Also Published As

Publication number Publication date
CA2405593A1 (en) 2001-11-29
JP2003534345A (ja) 2003-11-18
JP4043239B2 (ja) 2008-02-06
ES2214436T3 (es) 2004-09-16
TR200400723T4 (tr) 2004-06-21
EP1289997B1 (en) 2004-01-07
DE60101739T2 (de) 2004-12-09
EP1289997A1 (en) 2003-03-12
CA2405593C (en) 2009-12-22
WO2001090110A1 (en) 2001-11-29
GB0012383D0 (en) 2000-07-12
ATE257481T1 (de) 2004-01-15
US6706727B1 (en) 2004-03-16
JP2007254483A (ja) 2007-10-04
CN1430620A (zh) 2003-07-16
DK1289997T3 (da) 2004-05-10
DE60101739D1 (de) 2004-02-12
PT1289997E (pt) 2004-05-31
AU2001278428A1 (en) 2001-12-03
CN1229381C (zh) 2005-11-30

Similar Documents

Publication Publication Date Title
IL129318A0 (en) Use of 1-benzyl-3- (substituted hetaryl)- fused pyrazole derivatives
AU4950993A (en) Combination of germicidal agents
IL176110A0 (en) Azabicyclic heterocycles as cannabinoid receptor modulators
BR0113643A (pt) Compostos de guanidinobenzamidas como agonistas de mc4-r e seus usos
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
HK1095139A1 (en) Azabicyclic heterocycles as cannabinoid receptor modulators
GB0007405D0 (en) Compounds
HK1054945A1 (en) Macrolides
NZ325837A (en) Carbamoyloxy derivatives of mutiline and their use as antibacterials
MX9702380A (es) Nuevas carboxamidas con actividad antifungica.
MY137156A (en) Dual nk1/nk3 derivatives
FI953748A (fi) Yhdisteitä, joilla on sekä voimakas kalsium antagonisti- että antioksidanttiaktiivisuus sekä niiden käyttö solua suojaavina aineina
CA2247848A1 (en) Nitric oxide donors capable of reducing toxicity from drugs
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
GB0031312D0 (en) Macrolides
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
NZ503897A (en) 3,6-hemiketals from the class of 9a-azalides
BRPI0017528B8 (pt) uso de uma composição contendo sal de cetotifeno
NZ332321A (en) 3-Descladinose-2,3-anhydroerythromycin derivatives and medicaments
NZ333926A (en) Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
ES8701193A1 (es) Un procedimiento para preparar derivados de acido griseolico
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
IL110831A0 (en) Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
CA2380455A1 (en) 9a-azalides with antibacterial activity

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150521